Mission Wealth Management LP Acquires Shares of 1,556 IQVIA Holdings Inc. (NYSE:IQV)

Mission Wealth Management LP bought a new position in shares of IQVIA Holdings Inc. (NYSE:IQV) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 1,556 shares of the medical research company’s stock, valued at approximately $360,000.

Several other large investors have also made changes to their positions in the company. AdvisorNet Financial Inc raised its position in shares of IQVIA by 327.6% in the 4th quarter. AdvisorNet Financial Inc now owns 124 shares of the medical research company’s stock valued at $29,000 after acquiring an additional 95 shares during the period. BKM Wealth Management LLC acquired a new stake in IQVIA in the fourth quarter worth $32,000. Activest Wealth Management acquired a new position in shares of IQVIA in the 4th quarter valued at $35,000. CVA Family Office LLC bought a new stake in shares of IQVIA in the 4th quarter valued at $43,000. Finally, CoreFirst Bank & Trust acquired a new stake in IQVIA during the 3rd quarter worth $44,000. Institutional investors and hedge funds own 89.62% of the company’s stock.

Wall Street Analyst Weigh In

IQV has been the subject of several recent analyst reports. Guggenheim downgraded IQVIA from a “buy” rating to a “neutral” rating in a report on Thursday, February 15th. Robert W. Baird dropped their target price on shares of IQVIA from $254.00 to $245.00 and set a “neutral” rating on the stock in a report on Friday. BTIG Research started coverage on shares of IQVIA in a report on Tuesday, February 13th. They issued a “buy” rating and a $285.00 price target for the company. Leerink Partnrs restated an “outperform” rating on shares of IQVIA in a report on Monday, February 26th. Finally, Barclays upped their target price on shares of IQVIA from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Thursday, February 15th. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $257.57.

IQVIA Stock Up 0.6 %

IQV opened at $223.39 on Friday. The company has a current ratio of 0.88, a quick ratio of 0.86 and a debt-to-equity ratio of 2.02. The stock’s fifty day simple moving average is $244.56 and its 200 day simple moving average is $223.84. IQVIA Holdings Inc. has a 1-year low of $167.42 and a 1-year high of $261.73. The stock has a market cap of $40.55 billion, a PE ratio of 30.52, a price-to-earnings-growth ratio of 2.15 and a beta of 1.52.

IQVIA (NYSE:IQV) last posted its earnings results on Wednesday, February 14th. The medical research company reported $2.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.82 by $0.02. IQVIA had a net margin of 9.01% and a return on equity of 29.17%. The company had revenue of $3.87 billion during the quarter, compared to analysts’ expectations of $3.80 billion. During the same quarter last year, the company posted $2.54 EPS. IQVIA’s quarterly revenue was up 3.5% compared to the same quarter last year. As a group, research analysts expect that IQVIA Holdings Inc. will post 10.12 earnings per share for the current year.

Insider Activity

In related news, insider Ari Bousbib sold 31,678 shares of IQVIA stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $250.53, for a total transaction of $7,936,289.34. Following the completion of the sale, the insider now directly owns 796,752 shares of the company’s stock, valued at approximately $199,610,278.56. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, insider Eric Sherbet sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $241.50, for a total transaction of $241,500.00. Following the transaction, the insider now directly owns 20,836 shares of the company’s stock, valued at $5,031,894. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Ari Bousbib sold 31,678 shares of the business’s stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $250.53, for a total value of $7,936,289.34. Following the completion of the sale, the insider now owns 796,752 shares of the company’s stock, valued at $199,610,278.56. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 41,285 shares of company stock valued at $10,331,003. 1.60% of the stock is owned by insiders.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.